Filing Flows › Tela Bio (TELA) › Recalls, complaints & regulation
Tela Bio (TELA): clinical trials
Tela Bio (TELA) beyond its filings: 4 active clinical trials.
Tela Bio's latest quarter
Tela Bio, Q2 2026: revenue $19.3M (-4% year over year), operating margin -48.1%, net loss $11.3M, operating cash flow −$9.4M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Tela Bio have?
4 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.